Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWAP-AC 2: Tailoring P2Y12 Inhibiting Therapy in PCI Patients Requiring Oral Anticoagulation
2021-001418-12Phase 4Completed
- Sponsor
- University of Florida
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in coronary arteriosclerosis, Atrial fibrillation (AFib) and venous thromboembolism (VTE) comparing Clopidogrel arm with Ticagrelor arm (2 arms). Primary endpoint: Platelet reactivity units (PRU) by VerifyNow. Started Jun 2021; status: completed.
02
Drugs
clopidogrelticagrelor
03
Conditions
coronary arteriosclerosisAtrial fibrillation (AFib)venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2021-001418-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001418-12.